Multi-Gene Assay Predicts Recurrence In Newly Diagnosed Breast Cancer
FOLFOX 4 Should Be First-Line Therapy For Advanced Disease, NCCTG Finds
Surgery Without Radiation Found Inadequate for DCIS
QOL With Femara Comparable To Placebo, Analysis Finds
EMEND Improved Emesis In Men And Women, Trials Find
Biopsies Could Be Reduced By Computer-Aided-Detection
Chemo+Radiation Preserves Voice, RTOG Study Finds
Low-Dose IFN Not Effective Against Melanoma, Study Finds
NeoPharm To Begin Phase III Trial For Glioblastoma
Elderly Men Say Physicians Are Recommending PSA Tests
NCI-Approved Protocols Listed
Trending Stories
- GOP-led Congress rejects Trump’s plans to gut medical research
Senate bill gives NIH a $400 million raise - U.S. News & World Report expands evaluation of outcomes in cancer subspecialties
- Vinay Prasad falls from grace at FDA upon flunking Trump political purity test
MAHA leaders agree on one point: COVID was mishandled. Is that enough to run science-based agencies? - Cancer Research Institute announces 2025 recipients of cancer immunotherapy awards
- USPSTF doesn’t lean right or left—it’s about data, not politics
- FY25 paylines drop to 4th percentile—a historic low—as NCI braces for Trump’s FY26 budget cuts